Brussels, Belgium

Isabelle Migeotte

USPTO Granted Patents = 12 



Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Uccle, BE (2009)
  • Brussels, BE (2008 - 2011)

Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovations of Isabelle Migeotte

Introduction

Isabelle Migeotte is an accomplished inventor based in Brussels, Belgium, known for her impactful contributions to the field of biochemistry and pharmacology. With a total of 12 patents to her name, Migeotte has been at the forefront of innovations that address significant health-related challenges.

Latest Patents

Among her latest patents, Migeotte has developed methods of making an antibody that binds a chemerin polypeptide. This invention relates to a G-protein coupled receptor and a novel ligand, providing groundbreaking screening assays for identifying candidate compounds that modulate receptor activity. Additionally, her patent for nucleic acids encoding ChemerinR ligands has similar applications, aiding in the diagnosis and treatment of diseases related to the dysregulation of G-protein coupled receptor signaling.

Career Highlights

Throughout her career, Isabelle Migeotte has worked at prominent companies such as Euroscreen S.A., contributing her expertise in the development of innovative therapeutic solutions. Her numerous patents reflect her dedication to advancing science and improving healthcare outcomes.

Collaborations

Migeotte has collaborated with esteemed colleagues, including Marc Parmentier and David Communi, sharing knowledge and expertise to enhance research in her field. These partnerships have played a crucial role in the success of her innovative projects and patents.

Conclusion

Isabelle Migeotte's work in inventing G-protein coupled receptor therapeutics has established her as a notable figure in her field. Her 12 patents signify not only her creativity and hard work but also her commitment to addressing important medical issues. As innovations continue to unfold, Migeotte remains a key player in enhancing our understanding and treatment of various disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…